UBQLN4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.671800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.626400E-01
Normal-vs-Stage2
4.701400E-01
Normal-vs-Stage3
9.289800E-01
Normal-vs-Stage4
1.707180E-01
Stage1-vs-Stage2
2.063600E-01
Stage1-vs-Stage3
8.070400E-01
Stage1-vs-Stage4
1.118350E-01
Stage2-vs-Stage3
4.923800E-01
Stage2-vs-Stage4
1.688950E-01
Stage3-vs-Stage4
2.599800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.306800E-01
Normal-vs-AfricanAmerican
1.858360E-01
Normal-vs-Asian
6.412300E-02
Caucasian-vs-AfricanAmerican
1.912840E-01
Caucasian-vs-Asian
1.224000E-01
AfricanAmerican-vs-Asian
5.480800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.161800E-01
Normal-vs-Female
6.465200E-01
Male-vs-Female
2.539200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.489600E-01
Normal-vs-Age(41-60Yrs)
5.455000E-01
Normal-vs-Age(61-80Yrs)
5.689600E-01
Normal-vs-Age(81-100Yrs)
4.311000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.282000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.171400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.338200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.004000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.810000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.139000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.175000E-01
Normal-vs-Daily Drinker
8.989800E-01
Normal-vs-Weekly Drinker
5.187700E-02
Normal-vs-Occasional Drinker
4.828200E-01
Normal-vs-Social Drinker
8.207400E-01
Non Drinker-vs-Daily Drinker
2.347600E-01
Non Drinker-vs-Weekly Drinker
1.972240E-01
Non Drinker-vs-Occasional Drinker
9.304800E-01
Non Drinker-vs-Social Drinker
3.150600E-01
Daily Drinker-vs-Weekly Drinker
6.784300E-02
Daily Drinker-vs-Occasional Drinker
2.825200E-01
Daily Drinker-vs-Social Drinker
9.170800E-01
Weekly Drinker-vs-Occasional Drinker
1.856590E-01
Weekly Drinker-vs-Social Drinker
7.328000E-02
Occasional Drinker-vs-Social Drinker
3.299800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.830200E-01
Normal-vs-Grade 2
1.170780E-01
Normal-vs-Grade 3
9.668100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.400410E-02
Grade 1-vs-Grade 3
2.532000E-02
Grade 1-vs-Grade 4
4.830200E-01
Grade 2-vs-Grade 3
9.854800E-01
Grade 2-vs-Grade 4
1.170780E-01
Grade 3-vs-Grade 4
9.668100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.197600E-01
Normal-vs-NonDiabetic
5.209800E-01
Diabetic-vs-NonDiabetic
2.373800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.610200E-01
Normal-vs-NoPancreatitis
6.008800E-01
Pancreatitis-vs-NoPancreatitis
5.061200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.230200E-01
Normal-vs-N1
5.383800E-01
N0-vs-N1
9.576200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.294400E-01
Normal-vs-TP53-NonMutant
2.023200E-01
TP53-Mutant-vs-TP53-NonMutant
1.340350E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
